ROR-gamma t inhibitor (Eli Lilly & Co)

N/A

Report date: 2025/03/20 09:40:39
NME

Base Information

Drug NameROR-gamma t inhibitor (Eli Lilly & Co)
Drug Alias Nameretinoic acid receptor-related orphan receptor C2 gamma t inhibitor (Eli Lilly & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonistsRetinoic acid receptor gamma inhibitors
TargetsNuclear receptor ROR-gammaRetinoic acid receptor gamma
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A